The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Global Gynecology Drugs Market Research Report 2024

Global Gynecology Drugs Market Research Report 2024

Publishing Date : Feb, 2024

License Type :
 

Report Code : 1718688

No of Pages : 98

 

Gynaecology is the field of medicine that focuses on women's reproductive health issues, including the diagnosis and treatment of diseases of the female reproductive organs. It is usually combined with obstetrics (OB/GYN).

The global Gynecology Drugs market was valued at US$ 48720 million in 2023 and is anticipated to reach US$ 62270 million by 2030, witnessing a CAGR of 3.1% during the forecast period 2024-2030.

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

This report aims to provide a comprehensive presentation of the global market for Gynecology Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Gynecology Drugs.

Report Scope

The Gynecology Drugs market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Gynecology Drugs market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided. 

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Gynecology Drugs companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

By Company

  •     Pfizer
  •     Roche
  •     AbbVie
  •     Bayer
  •     Merck
  •     Abbott Laboratories
  •     GlaxoSmithKline
  •     Johnson & Johnson
  •     Sanofi
  •     Novartis
  •     Eli Lilly
  •     AstraZeneca
  •     Allergan
  •     Amgen
  •     Chengdu Enwei Group

Segment by Type

  •     Hormonal Therapy
  •     Non-hormonal Therapy

Segment by Application

  •     Hospital Pharmacies
  •     Retail Pharmacies
  •     Online Pharmacies

By Region

  • North America (United States, Canada)
  • Europe (Germany, France, U.K., Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, India, Australia, China Taiwan, Indonesia, Thailand, Malaysia)
  • Latin America (Mexico, Brazil, Argentina, Colombia)

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Gynecology Drugs companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

 1 Report Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global Gynecology Drugs Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
        1.2.2 Hormonal Therapy
        1.2.3 Non-hormonal Therapy
    1.3 Market by Application
        1.3.1 Global Gynecology Drugs Market Growth by Application: 2019 VS 2023 VS 2030
        1.3.2 Hospital Pharmacies
        1.3.3 Retail Pharmacies
        1.3.4 Online Pharmacies
    1.4 Study Objectives
    1.5 Years Considered
    1.6 Years Considered

 2 Global Growth Trends
    2.1 Global Gynecology Drugs Market Perspective (2019-2030)
    2.2 Gynecology Drugs Growth Trends by Region
        2.2.1 Global Gynecology Drugs Market Size by Region: 2019 VS 2023 VS 2030
        2.2.2 Gynecology Drugs Historic Market Size by Region (2019-2024)
        2.2.3 Gynecology Drugs Forecasted Market Size by Region (2025-2030)
    2.3 Gynecology Drugs Market Dynamics
        2.3.1 Gynecology Drugs Industry Trends
        2.3.2 Gynecology Drugs Market Drivers
        2.3.3 Gynecology Drugs Market Challenges
        2.3.4 Gynecology Drugs Market Restraints

 3 Competition Landscape by Key Players
    3.1 Global Top Gynecology Drugs Players by Revenue
        3.1.1 Global Top Gynecology Drugs Players by Revenue (2019-2024)
        3.1.2 Global Gynecology Drugs Revenue Market Share by Players (2019-2024)
    3.2 Global Gynecology Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    3.3 Players Covered: Ranking by Gynecology Drugs Revenue
    3.4 Global Gynecology Drugs Market Concentration Ratio
        3.4.1 Global Gynecology Drugs Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by Gynecology Drugs Revenue in 2023
    3.5 Gynecology Drugs Key Players Head office and Area Served
    3.6 Key Players Gynecology Drugs Product Solution and Service
    3.7 Date of Enter into Gynecology Drugs Market
    3.8 Mergers & Acquisitions, Expansion Plans

 4 Gynecology Drugs Breakdown Data by Type
    4.1 Global Gynecology Drugs Historic Market Size by Type (2019-2024)
    4.2 Global Gynecology Drugs Forecasted Market Size by Type (2025-2030)

 5 Gynecology Drugs Breakdown Data by Application
    5.1 Global Gynecology Drugs Historic Market Size by Application (2019-2024)
    5.2 Global Gynecology Drugs Forecasted Market Size by Application (2025-2030)

 6 North America
    6.1 North America Gynecology Drugs Market Size (2019-2030)
    6.2 North America Gynecology Drugs Market Growth Rate by Country: 2019 VS 2023 VS 2030
    6.3 North America Gynecology Drugs Market Size by Country (2019-2024)
    6.4 North America Gynecology Drugs Market Size by Country (2025-2030)
    6.5 United States
    6.6 Canada

 7 Europe
    7.1 Europe Gynecology Drugs Market Size (2019-2030)
    7.2 Europe Gynecology Drugs Market Growth Rate by Country: 2019 VS 2023 VS 2030
    7.3 Europe Gynecology Drugs Market Size by Country (2019-2024)
    7.4 Europe Gynecology Drugs Market Size by Country (2025-2030)
    7.5 Germany
    7.6 France
    7.7 U.K.
    7.8 Italy
    7.9 Russia
    7.10 Nordic Countries

 8 Asia-Pacific
    8.1 Asia-Pacific Gynecology Drugs Market Size (2019-2030)
    8.2 Asia-Pacific Gynecology Drugs Market Growth Rate by Region: 2019 VS 2023 VS 2030
    8.3 Asia-Pacific Gynecology Drugs Market Size by Region (2019-2024)
    8.4 Asia-Pacific Gynecology Drugs Market Size by Region (2025-2030)
    8.5 China
    8.6 Japan
    8.7 South Korea
    8.8 Southeast Asia
    8.9 India
    8.10 Australia

 9 Latin America
    9.1 Latin America Gynecology Drugs Market Size (2019-2030)
    9.2 Latin America Gynecology Drugs Market Growth Rate by Country: 2019 VS 2023 VS 2030
    9.3 Latin America Gynecology Drugs Market Size by Country (2019-2024)
    9.4 Latin America Gynecology Drugs Market Size by Country (2025-2030)
    9.5 Mexico
    9.6 Brazil

 10 Middle East & Africa
    10.1 Middle East & Africa Gynecology Drugs Market Size (2019-2030)
    10.2 Middle East & Africa Gynecology Drugs Market Growth Rate by Country: 2019 VS 2023 VS 2030
    10.3 Middle East & Africa Gynecology Drugs Market Size by Country (2019-2024)
    10.4 Middle East & Africa Gynecology Drugs Market Size by Country (2025-2030)
    10.5 Turkey
    10.6 Saudi Arabia
    10.7 UAE

 11 Key Players Profiles
    11.1 Pfizer
        11.1.1 Pfizer Company Detail
        11.1.2 Pfizer Business Overview
        11.1.3 Pfizer Gynecology Drugs Introduction
        11.1.4 Pfizer Revenue in Gynecology Drugs Business (2019-2024)
        11.1.5 Pfizer Recent Development
    11.2 Roche
        11.2.1 Roche Company Detail
        11.2.2 Roche Business Overview
        11.2.3 Roche Gynecology Drugs Introduction
        11.2.4 Roche Revenue in Gynecology Drugs Business (2019-2024)
        11.2.5 Roche Recent Development
    11.3 AbbVie
        11.3.1 AbbVie Company Detail
        11.3.2 AbbVie Business Overview
        11.3.3 AbbVie Gynecology Drugs Introduction
        11.3.4 AbbVie Revenue in Gynecology Drugs Business (2019-2024)
        11.3.5 AbbVie Recent Development
    11.4 Bayer
        11.4.1 Bayer Company Detail
        11.4.2 Bayer Business Overview
        11.4.3 Bayer Gynecology Drugs Introduction
        11.4.4 Bayer Revenue in Gynecology Drugs Business (2019-2024)
        11.4.5 Bayer Recent Development
    11.5 Merck
        11.5.1 Merck Company Detail
        11.5.2 Merck Business Overview
        11.5.3 Merck Gynecology Drugs Introduction
        11.5.4 Merck Revenue in Gynecology Drugs Business (2019-2024)
        11.5.5 Merck Recent Development
    11.6 Abbott Laboratories
        11.6.1 Abbott Laboratories Company Detail
        11.6.2 Abbott Laboratories Business Overview
        11.6.3 Abbott Laboratories Gynecology Drugs Introduction
        11.6.4 Abbott Laboratories Revenue in Gynecology Drugs Business (2019-2024)
        11.6.5 Abbott Laboratories Recent Development
    11.7 GlaxoSmithKline
        11.7.1 GlaxoSmithKline Company Detail
        11.7.2 GlaxoSmithKline Business Overview
        11.7.3 GlaxoSmithKline Gynecology Drugs Introduction
        11.7.4 GlaxoSmithKline Revenue in Gynecology Drugs Business (2019-2024)
        11.7.5 GlaxoSmithKline Recent Development
    11.8 Johnson & Johnson
        11.8.1 Johnson & Johnson Company Detail
        11.8.2 Johnson & Johnson Business Overview
        11.8.3 Johnson & Johnson Gynecology Drugs Introduction
        11.8.4 Johnson & Johnson Revenue in Gynecology Drugs Business (2019-2024)
        11.8.5 Johnson & Johnson Recent Development
    11.9 Sanofi
        11.9.1 Sanofi Company Detail
        11.9.2 Sanofi Business Overview
        11.9.3 Sanofi Gynecology Drugs Introduction
        11.9.4 Sanofi Revenue in Gynecology Drugs Business (2019-2024)
        11.9.5 Sanofi Recent Development
    11.10 Novartis
        11.10.1 Novartis Company Detail
        11.10.2 Novartis Business Overview
        11.10.3 Novartis Gynecology Drugs Introduction
        11.10.4 Novartis Revenue in Gynecology Drugs Business (2019-2024)
        11.10.5 Novartis Recent Development
    11.11 Eli Lilly
        11.11.1 Eli Lilly Company Detail
        11.11.2 Eli Lilly Business Overview
        11.11.3 Eli Lilly Gynecology Drugs Introduction
        11.11.4 Eli Lilly Revenue in Gynecology Drugs Business (2019-2024)
        11.11.5 Eli Lilly Recent Development
    11.12 AstraZeneca
        11.12.1 AstraZeneca Company Detail
        11.12.2 AstraZeneca Business Overview
        11.12.3 AstraZeneca Gynecology Drugs Introduction
        11.12.4 AstraZeneca Revenue in Gynecology Drugs Business (2019-2024)
        11.12.5 AstraZeneca Recent Development
    11.13 Allergan
        11.13.1 Allergan Company Detail
        11.13.2 Allergan Business Overview
        11.13.3 Allergan Gynecology Drugs Introduction
        11.13.4 Allergan Revenue in Gynecology Drugs Business (2019-2024)
        11.13.5 Allergan Recent Development
    11.14 Amgen
        11.14.1 Amgen Company Detail
        11.14.2 Amgen Business Overview
        11.14.3 Amgen Gynecology Drugs Introduction
        11.14.4 Amgen Revenue in Gynecology Drugs Business (2019-2024)
        11.14.5 Amgen Recent Development
    11.15 Chengdu Enwei Group
        11.15.1 Chengdu Enwei Group Company Detail
        11.15.2 Chengdu Enwei Group Business Overview
        11.15.3 Chengdu Enwei Group Gynecology Drugs Introduction
        11.15.4 Chengdu Enwei Group Revenue in Gynecology Drugs Business (2019-2024)
        11.15.5 Chengdu Enwei Group Recent Development

 12 Analyst's Viewpoints/Conclusions

 13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Disclaimer
    13.3 Author Details

Published By : QY Research

Why ‘The Market Reports’